Home > Healthcare > Biotechnology > Biopharma > Recombinant Proteins Market
Recombinant Proteins Market Size
- Report ID: GMI9114
- Published Date: Apr 2024
- Report Format: PDF
Recombinant Proteins Market Size
Recombinant Proteins Market was valued at USD 2.3 billion in 2023 and is anticipated to witness more than 7.1% CAGR from 2024 to 2032. One of the primary drivers is the increasing demand for biopharmaceuticals and therapeutic proteins, which are essential in the treatment of various diseases such as cancer, diabetes, and autoimmune disorders. Additionally, the growing aging population coupled with rising prevalence of chronic diseases worldwide, is increasing the need for innovative treatment options, further propelling the demand for recombinant proteins.
Recombinant proteins are artificially created by combining DNA sequences from two different sources. This is typically done by inserting the desired DNA sequence into a host organism, such as bacteria, yeast, or mammalian cells, which then produce the protein encoded by that sequence. Recombinant proteins are widely used in research, diagnostics, and therapeutics, as they allow to produce large quantities of specific proteins that may be difficult or impossible to isolate from natural sources.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Recombinant Proteins Market Size in 2023: | USD 2.3 Billion |
| Forecast Period: | 2024 - 2032 |
| Forecast Period 2024 - 2032 CAGR: | 7.1% |
| 2032 Value Projection: | USD 4.1 Billion |
| Historical Data for: | 2021 - 2023 |
| No. of Pages: | 298 |
| Tables, Charts & Figures: | 515 |
| Segments covered: | Products & Services, Application, Host-Cell, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Recombinant Proteins Market Scope
